vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $85.1M, roughly 1.2× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 11.6%, a 11.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 8.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $6.2M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 1.0%).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

CSV vs FDMT — Head-to-Head

Bigger by revenue
CSV
CSV
1.2× larger
CSV
$105.5M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508892.0% gap
FDMT
8508900.0%
8.0%
CSV
Higher net margin
FDMT
FDMT
11.2% more per $
FDMT
22.8%
11.6%
CSV
More free cash flow
FDMT
FDMT
$22.3M more FCF
FDMT
$28.5M
$6.2M
CSV
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
1.0%
CSV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
FDMT
FDMT
Revenue
$105.5M
$85.1M
Net Profit
$12.3M
$19.4M
Gross Margin
34.8%
Operating Margin
23.3%
17.3%
Net Margin
11.6%
22.8%
Revenue YoY
8.0%
8508900.0%
Net Profit YoY
24.5%
139.1%
EPS (diluted)
$0.76
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
FDMT
FDMT
Q4 25
$105.5M
$85.1M
Q3 25
$102.7M
$90.0K
Q2 25
$102.1M
$15.0K
Q1 25
$107.1M
$14.0K
Q4 24
$97.7M
$1.0K
Q3 24
$100.7M
$3.0K
Q2 24
$102.3M
$5.0K
Q1 24
$103.5M
$28.0K
Net Profit
CSV
CSV
FDMT
FDMT
Q4 25
$12.3M
$19.4M
Q3 25
$6.6M
$-56.9M
Q2 25
$11.7M
$-54.7M
Q1 25
$20.9M
$-48.0M
Q4 24
$9.9M
Q3 24
$9.9M
$-43.8M
Q2 24
$6.3M
$-35.0M
Q1 24
$7.0M
$-32.4M
Gross Margin
CSV
CSV
FDMT
FDMT
Q4 25
34.8%
Q3 25
35.3%
Q2 25
35.2%
Q1 25
35.3%
Q4 24
34.4%
Q3 24
35.2%
Q2 24
36.2%
Q1 24
36.0%
Operating Margin
CSV
CSV
FDMT
FDMT
Q4 25
23.3%
17.3%
Q3 25
17.0%
-67983.3%
Q2 25
23.5%
-396373.3%
Q1 25
29.5%
-383007.1%
Q4 24
21.6%
Q3 24
22.7%
-1704400.0%
Q2 24
18.0%
-849120.0%
Q1 24
18.8%
-136200.0%
Net Margin
CSV
CSV
FDMT
FDMT
Q4 25
11.6%
22.8%
Q3 25
6.4%
-63195.6%
Q2 25
11.5%
-364386.7%
Q1 25
19.5%
-342657.1%
Q4 24
10.1%
Q3 24
9.8%
-1461433.3%
Q2 24
6.1%
-699060.0%
Q1 24
6.7%
-115717.9%
EPS (diluted)
CSV
CSV
FDMT
FDMT
Q4 25
$0.76
$0.43
Q3 25
$0.41
$-1.01
Q2 25
$0.74
$-0.98
Q1 25
$1.34
$-0.86
Q4 24
$0.62
Q3 24
$0.63
$-0.79
Q2 24
$0.40
$-0.63
Q1 24
$0.45
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$1.7M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$254.8M
$505.7M
Total Assets
$1.3B
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
FDMT
FDMT
Q4 25
$1.7M
$402.7M
Q3 25
$1.2M
$305.1M
Q2 25
$1.4M
$293.2M
Q1 25
$4.6M
$321.4M
Q4 24
$1.2M
$424.9M
Q3 24
$1.3M
$501.9M
Q2 24
$1.5M
$541.9M
Q1 24
$1.7M
$525.9M
Stockholders' Equity
CSV
CSV
FDMT
FDMT
Q4 25
$254.8M
$505.7M
Q3 25
$242.1M
$369.0M
Q2 25
$235.4M
$420.9M
Q1 25
$223.1M
$469.7M
Q4 24
$208.6M
$510.6M
Q3 24
$198.1M
$552.9M
Q2 24
$187.9M
$588.3M
Q1 24
$179.6M
$600.6M
Total Assets
CSV
CSV
FDMT
FDMT
Q4 25
$1.3B
$566.7M
Q3 25
$1.3B
$424.0M
Q2 25
$1.3B
$473.6M
Q1 25
$1.3B
$515.7M
Q4 24
$1.3B
$560.4M
Q3 24
$1.3B
$604.0M
Q2 24
$1.3B
$620.1M
Q1 24
$1.3B
$629.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
FDMT
FDMT
Operating Cash FlowLast quarter
$14.1M
$28.6M
Free Cash FlowOCF − Capex
$6.2M
$28.5M
FCF MarginFCF / Revenue
5.9%
33.5%
Capex IntensityCapex / Revenue
7.5%
0.1%
Cash ConversionOCF / Net Profit
1.15×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
FDMT
FDMT
Q4 25
$14.1M
$28.6M
Q3 25
$24.7M
$-46.5M
Q2 25
$8.1M
$-43.4M
Q1 25
$13.8M
$-47.8M
Q4 24
$9.3M
$-134.6M
Q3 24
$20.9M
$-29.4M
Q2 24
$2.2M
$-30.2M
Q1 24
$19.7M
$-29.1M
Free Cash Flow
CSV
CSV
FDMT
FDMT
Q4 25
$6.2M
$28.5M
Q3 25
$18.0M
$-46.6M
Q2 25
$5.2M
$-43.4M
Q1 25
$10.6M
$-48.4M
Q4 24
$4.9M
$-138.4M
Q3 24
$16.2M
$-31.2M
Q2 24
$-1.4M
$-30.6M
Q1 24
$16.2M
$-29.8M
FCF Margin
CSV
CSV
FDMT
FDMT
Q4 25
5.9%
33.5%
Q3 25
17.5%
-51765.6%
Q2 25
5.1%
-289620.0%
Q1 25
9.9%
-345635.7%
Q4 24
5.0%
-13837100.0%
Q3 24
16.1%
-1038966.7%
Q2 24
-1.4%
-611840.0%
Q1 24
15.6%
-106421.4%
Capex Intensity
CSV
CSV
FDMT
FDMT
Q4 25
7.5%
0.1%
Q3 25
6.5%
101.1%
Q2 25
2.8%
440.0%
Q1 25
3.0%
4507.1%
Q4 24
4.5%
378600.0%
Q3 24
4.6%
59266.7%
Q2 24
3.5%
6980.0%
Q1 24
3.4%
2535.7%
Cash Conversion
CSV
CSV
FDMT
FDMT
Q4 25
1.15×
1.47×
Q3 25
3.76×
Q2 25
0.69×
Q1 25
0.66×
Q4 24
0.94×
Q3 24
2.11×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

FDMT
FDMT

Segment breakdown not available.

Related Comparisons